arrow
S

Séverine Le Roy

university of toulouse and cnrs
H指数:32
被引数:4,618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NivoLag-when: International real-world study of combination immunotherapy sequences in melanoma

NivoLag-when: 黑色素瘤中联合免疫疗法序列的国际真实世界研究

2024-09-010
PRE
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy

切除的III/IV期肢端或粘膜黑色素瘤患者的结果,以anti-PD-1为基础的辅助治疗

2024-03-016
PRE
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy

放射组学评估病变间异质性,并使用经验证的CD8细胞特征预测病变反应和患者预后接受anti-PD1免疫治疗的晚期黑色素瘤患者

2022-10-2817
OAAI
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
2022-07-0627
OAAI
SAFETY AND EFFICACY OF INTRATUMORAL IPILIMUMAB WITH IV NIVOLUMAB IN METASTATIC MELANOMA. THE NIVIPIT TRIAL
2021-11-106
OA
Immune Checkpoint Inhibitor Therapy Aggravates T Cell-Driven Plaque Inflammation in Atherosclerosis
2020-11-0193
OAAI
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
2020-10-2239
OAAI